Although intravenous vasodilators such as nesiritide and nitroprusside can improve hemodynamics, their renal effects are neutral and unlikely to improve renal function. [81–83] In the ASCEND-HF ...

In this review, we discuss the current understanding of the cardiovascular consequences of acute kidney injury (i.e., type 3 cardiorenal syndrome).